August 1st 2025
Four-year data show lecanemab slows clinical decline in early Alzheimer disease and maintains a consistent safety profile.
Total Sodium in the Brain Increases Dramatically in Advanced Relapse-Remitting Multiple Sclerosis
January 8th 2013Sodium levels are known to be elevated inside the brain stem, cerebellum, and temporal poles early in the course of MS. This study showed total sodium concentrations to be significantly increased in advanced disease-particularly in normal-appearing brain tissues, concomitant with disability.